Bleeding patterns with low-dose, monophasic oral contraceptives.

Area of Science:

• Reproductive Health
• Pharmacology
• Gynecology

Background:

• Oral contraceptives (OCs) are widely used for cycle control and contraception.
• Understanding intermenstrual bleeding (IMB) is crucial for OC efficacy and user satisfaction.
• Low-dose formulations aim to minimize side effects while maintaining cycle control.

Purpose of the Study:

• To analyze cycle control over 12 months using two low-dose oral contraceptive formulations.
• To compare intermenstrual bleeding (IMB) patterns between different OC formulations and user groups.
• To assess the impact of prior OC use on IMB incidence.

Main Methods:

• A 12-month prospective study analyzing bleeding patterns on pill-taking days 1-21.
• Two low-dose OCs were used: norethindrone/ethinyl estradiol (NET + EE) and norgestrel/ethinyl estradiol (Ng + EE).
• Participants were categorized as 'fresh' (no OCs for ≥2 months) or 'switch-over' (prior OCs with ≥0.05 mg estrogen).

Main Results:

• Fresh OC users reported more IMB than switch-over users, particularly in the first three cycles.
• IMB incidence decreased over time for both user groups.
• Ng + EE formulations resulted in fewer IMB episodes during early cycles compared to NET + EE.
• NET + EE users exhibited a characteristic W-shaped daily IMB incidence curve, most prominent in early cycles.

Conclusions:

• Cycle control with low-dose OCs is influenced by formulation and prior user status.
• The Ng + EE formulation demonstrates potentially better early cycle control regarding IMB.
• Further research into IMB patterns can optimize OC selection and improve user adherence.